Tiny trial tests new lead for implanted defibrillator
NCT ID NCT06592001
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This early study tests a new type of lead (a wire) for an implantable cardioverter-defibrillator (ICD) in 19 people who need one. The lead is placed under the breastbone to deliver a shock if the heart beats dangerously fast. The goal is to see if it is safe and works well enough to plan a larger study.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
AtaCor EV-ICD Atala™ lead (implanted device)
What this could lead to
If successful, this could lead to a safer, more effective way to deliver life-saving shocks from an implantable defibrillator to prevent sudden cardiac death.
What could go wrong
This is a very small, early feasibility study with only 19 people and no control group. The device may not work as expected or could cause complications like infection or lead failure.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VENTRICULAR ARRYTHMIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Christchurch Hospital
Christchurch, New Zealand
-
Sanatorio Italiano
Asunción, Paraguay
-
University Hospital Center Split
Split, 21000, Croatia